Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Agenus, Astrazeneca, Atea, Bioarctic, Biophytis, Botanix, Corvus, Covaxx, Daiichi Sankyo, Dong-A, Dynavax Technologies, Eiger, Eisai, Enlivex, Eucure, Glaxosmithkline, Golden, I-Mab, Innocare, Junshi, Neurorx, Reistone, Sanofi, Sinovac, Vaxart, Veru.